<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>Shameless Experimentation on Wounded U.S. Soldiers Fighting in Iraq</title><link>http://articles.mercola.com/sites/articles/archive/2006/12/05/shameless-experimentation-on-wounded-us-soldiers-fighting-in-iraq.aspx</link><description>Recombinant Activated Factor VII, a blood coagulant made by Danish pharmaceutical company Novo Nordisk and sold under the name NovoSeven, was approved only for treating people with a rare form of inherited hemophilia when it was introduced in 1999. However</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>